Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors.

Peretz J, Pekosz A, Lane AP, Klein SL.

Am J Physiol Lung Cell Mol Physiol. 2016 Mar 1;310(5):L415-25. doi: 10.1152/ajplung.00398.2015. Epub 2015 Dec 18.

2.

Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells.

Fischer WA 2nd, King LS, Lane AP, Pekosz A.

Vaccine. 2015 Aug 26;33(36):4495-504. doi: 10.1016/j.vaccine.2015.07.023. Epub 2015 Jul 18.

3.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

4.

Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Fischer WA 2nd, Chason KD, Brighton M, Jaspers I.

Vaccine. 2014 Mar 26;32(15):1761-7. doi: 10.1016/j.vaccine.2013.12.069. Epub 2014 Jan 30.

5.

Methamphetamine reduces human influenza A virus replication.

Chen YH, Wu KL, Chen CH.

PLoS One. 2012;7(11):e48335. doi: 10.1371/journal.pone.0048335. Epub 2012 Nov 6.

6.

Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.

Betts RJ, Mann TS, Henry PJ.

J Pharmacol Exp Ther. 2012 Dec;343(3):725-35. doi: 10.1124/jpet.112.196485. Epub 2012 Sep 17.

PMID:
22988062
7.

Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells.

Hirakawa S, Kojima T, Obata K, Okabayashi T, Yokota S, Nomura K, Obonai T, Fuchimoto J, Himi T, Tsutsumi H, Sawada N.

J Med Virol. 2013 Dec;85(12):2141-50. doi: 10.1002/jmv.23718. Epub 2013 Sep 5.

PMID:
24009192
8.

Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication.

Berri F, Haffar G, Lê VB, Sadewasser A, Paki K, Lina B, Wolff T, Riteau B.

J Virol. 2014 Oct;88(19):11215-28. doi: 10.1128/JVI.01405-14. Epub 2014 Jul 16.

10.

Fluorescence-Activated Cell Sorting-Based Analysis Reveals an Asymmetric Induction of Interferon-Stimulated Genes in Response to Seasonal Influenza A Virus.

von Recum-Knepper J, Sadewasser A, Weinheimer VK, Wolff T.

J Virol. 2015 Jul;89(14):6982-93. doi: 10.1128/JVI.00857-15. Epub 2015 Apr 22.

11.

Magnitude of influenza virus replication and cell damage is associated with interleukin-6 production in primary cultures of human tracheal epithelium.

Yamaya M, Nadine LK, Ota C, Kubo H, Makiguchi T, Nagatomi R, Nishimura H.

Respir Physiol Neurobiol. 2014 Oct 1;202:16-23. doi: 10.1016/j.resp.2014.07.010. Epub 2014 Jul 23.

PMID:
25064661
12.

Differentiated swine airway epithelial cell cultures for the investigation of influenza A virus infection and replication.

Bateman AC, Karasin AI, Olsen CW.

Influenza Other Respir Viruses. 2013 Mar;7(2):139-50. doi: 10.1111/j.1750-2659.2012.00371.x. Epub 2012 Apr 25.

13.

The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.

Yamaya M, Shimotai Y, Hatachi Y, Lusamba Kalonji N, Tando Y, Kitajima Y, Matsuo K, Kubo H, Nagatomi R, Hongo S, Homma M, Nishimura H.

Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10.

PMID:
26166259
14.

Elevated 17β-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses.

Robinson DP, Lorenzo ME, Jian W, Klein SL.

PLoS Pathog. 2011 Jul;7(7):e1002149. doi: 10.1371/journal.ppat.1002149. Epub 2011 Jul 28.

15.

Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation.

Musiol A, Gran S, Ehrhardt C, Ludwig S, Grewal T, Gerke V, Rescher U.

MBio. 2013 Nov 5;4(6):e00608-13. doi: 10.1128/mBio.00608-13.

16.

Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway.

Barbier D, Garcia-Verdugo I, Pothlichet J, Khazen R, Descamps D, Rousseau K, Thornton D, Si-Tahar M, Touqui L, Chignard M, Sallenave JM.

Am J Respir Cell Mol Biol. 2012 Aug;47(2):149-57. doi: 10.1165/rcmb.2011-0405OC. Epub 2012 Mar 1.

PMID:
22383584
17.

Emerging cellular targets for influenza antiviral agents.

Müller KH, Kakkola L, Nagaraj AS, Cheltsov AV, Anastasina M, Kainov DE.

Trends Pharmacol Sci. 2012 Feb;33(2):89-99. doi: 10.1016/j.tips.2011.10.004. Epub 2011 Dec 22. Review.

PMID:
22196854
18.

The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium.

Yamaya M, Nadine L, Kubo H, Saito K, Saito R, Nishimura H.

J Med Virol. 2015 Jan;87(1):25-34. doi: 10.1002/jmv.23974. Epub 2014 May 16.

PMID:
24838828
19.

Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG, Reading PC.

J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30.

20.

Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus.

Kosmider B, Messier EM, Janssen WJ, Nahreini P, Wang J, Hartshorn KL, Mason RJ.

Respir Res. 2012 Jun 6;13:43. doi: 10.1186/1465-9921-13-43.

Supplemental Content

Support Center